Advertisement

PharmacoEconomics & Outcomes News

, Volume 817, Issue 1, pp 11–11 | Cite as

CEA of 3 vs 6 months' adjuvant chemotherapy in colorectal cancer

Clinical study
  • 3 Downloads

Reference

  1. Robles-Zurita J, et al. SCOT: a comparison of cost-effectiveness from a large randomised phase III trial of two durations of adjuvant Oxaliplatin combination chemotherapy for colorectal cancer. British Journal of Cancer : 13 Nov 2018. Available from: URL: http://doi.org/10.1038/s41416-018-0319-z

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations